Moreover, Jacob et al. reported that CD44 indicated a significantly worse prognosis for survival, while ALDH1 had protective properties in HNSCC survival [50], indicating that they are not prognostic in all HNSCC cohorts. The gene discussed is CD44; the disease is head and neck squamous cell carcinoma.